| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.9M | +73.1% |
| SG&A Expense | $15.0M | +34.5% |
| Operating Income | -$24.9M | -47.6% |
| Net Income | -$24.7M | -49.3% |
| EPS (Basic) | -$2.20 | -15.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -91.7% |
| Short-term Investments | $34.5M | — |
| Current Assets | $39.4M | -28.4% |
| Total Assets | $41.7M | -27.8% |
| Current Liabilities | $1.5M | -3.2% |
| Total Liabilities | $2.9M | -11.0% |
| Stockholders' Equity | $38.7M | -28.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.6M | -31.9% |
| Capital Expenditures | $115K | -68.7% |
| Investing Cash Flow | -$34.6M | -9292.5% |
| Financing Cash Flow | $57.6M | +0.0% |
| Free Cash Flow | -$15.7M | -28.8% |